Spondyloarthropathies in sub-Saharan Africa

Current Opinion in Rheumatology

Volumn 12, Issue 4, 2000, Pages 281-286

  Mijiyawa, Moustafa ^a,c   Oniankitan, Owonayo ^a   Khan, Muhammad Asim ^b  

^a UNIVERSITÉ DE LOMÉ   (Togo)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (Togo)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN;

AFRICA SOUTH OF THE SAHARA; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; EPIDEMIC; FAMILIAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRIDOCYCLITIS; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; SPONDYLOARTHROPATHY;

AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ARTHRITIS, PSORIATIC; ARTHRITIS, REACTIVE; GASTROENTERITIS; HIV INFECTIONS; HLA-B27 ANTIGEN; HUMANS; SPONDYLITIS, ANKYLOSING;

EID: 0033948424     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200007000-00008     Document Type: Article

References (49)

1. 1 Chalmers IM: Ankylosing spondylitis in African Blacks. Arthritis Rheum 1980, 23:1366-1370.
2. 2 Stein M, Davis P, Emmanual J, West G: The spondyloarthropathies in Zimbabwe: a clinical and immunogenetic profile. J Rheumatol 1990, 17:1337-1339.
3. 3 Mijiyawa M: Spondyloarthropathies in patients attending the rheumatology unit of Lomé hospital. J Rheumatol 1993, 20:1167-1169.
4. 4 Khan MA: Spondyloarthropathies in non-Caucasian populations of the world. Adv Inflamm Res 1985, 9:91-99.
5. 5 Khan MA: A worldwide overview: the epidemiology of HLA-B27 and associated spondyloarthritides. In The Spondylarthritides. Edited by Calin A, Taurog J. Oxford: Oxford University Press; 1998:17-26.
6. 6 Seedat YK, Duminiet H: Reiter's syndrome in a black patient. S Afr Med J 1982; 61:289.
7. 7 Methven PG, Swift PJ: Reiter's syndrome in a black patient: a case report. S Afr Med J 1985, 68:597-598.
8. 8 Njobvu P, McGill P, Kerr H, et al.: Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998, 25:1553-1559.
9. 9 Njobvu P, McGill PE: Is HIV the culprit? Spondyloarthropathy in the Third World [editorial]. J Rheumatol 1999, 26:2074-2075.
10. 10 Njobvu P, McGill PE: Psoriatic arthritis associated with HIV infection in Zambia. Arthritis Rheum 1999, 42(suppl 9):S398. A very informative report, but only available as an abstract; the full paper is expected to be published soon.
11. 11 Stein CM, Davis P: Arthritis associated with HIV infection in Zimbabwe. J Rheumatol 1996, 23:506-511.
12. 12 Blanche P, Taelman H, Saraux A, et al.: Acute arthritis and human immunodeficiency virus infection in Rwanda. J Rheumatol 1993, 20:2123-2127.
13. 13 Cuéllar ML, Espinoza LR: Human immunodeficiency virus associated spondyloarthropathy: lessons from the Third World [editorial]. J Rheumatol 1999, 26:2071-2073.
14. 14 Lau CS, Burgos-Vargas R, Louthrenoo W, et al.: Features of spondyloarthritis around the world. Rheum Dis Clin North Am 1998, 24:753-770.
15. 15 Burch VC, Isaacs S, Kalla AA: Ethnicity and patterns of spondyloarthritis in South Africa: analysis of 100 patients. J Rheumatol 1999, 26:2195-2200. A retrospective study of 100 new cases of spondyloarthropathy identified at the Rheumatology Disease Unit at the University of Cape Town between January 1988 and January 1995. Black ethnic groups make up at least 22% of the estimated 1.9 million residents of Cape Peninsula, but only five black patients (5%) (three with ankylosing spondylitis and two with reactive arthritis) were observed during the 7 years of the study.
16. 16 Mbayo K, Mbuyi-Muamba JM, Lurhuma AZ, et al.: Low frequency of HLA B27 and scarcity of ankylosing spondylitis in a Zairean Bantu population. Clin Rheumatol 1998, 17:309-310.
17. 17 Du Toit ED, MacGregor KJ, Taljaard DG, Oudshoorn M: HLA-A, B, C, DR and DQ polymorphisms in three South African population groups: South African Negroes, Cape Coloured and South African caucasoids. Tissue Antigens 1988, 31:109-125.
18. 18 Okoye RC, Ollier W, Jaraquernada D, et al.: HLA-D region heterogeneity in a Nigerian population. Tissue Antigens 1989, 33:445-456.
19. 19 Brown MA, Jepson A, Young A, et al.: Ankylosing spondylitis in West Africans: evidence for non-HLA B27 protective effect. Ann Rheum Dis 1997, 56:68-70.
20. 20 Kalidi I, Fofana Y, Rahly AA, et al.: Study of HLA antigens in a population of Mali (West Africa). Tissue Antigens 1988, 31:98-102.
21. 21 Hill AVS, Allsopp CEM, Kwiatkowski D, et al.: HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet 1991, 337:640-642.
22. 22 Khan MA, Braun WE, Kushner I, et al.: HLA-B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and Caucasians. J Rheumatol 1977, 4(suppl 3):39-43.
23. 23 Khan MA, Khan MK: Diagnostic value of HLA-B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Intern Med 1982, 96:70-76.
24. 24 Khan MA: How the B27 test can help in the diagnosis of spondyloarthropathies. In Spondylarthropathies. Edited by Calin A, New York: Grune & Stratton; 1984:323-337.
25. 25 Khan MA, Kushner I, Braun WE: Comparison of clinical features of HLA-B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 1997, 20:909-912.
26. 26 Winchester R, Bernstein DH, Fischer HD, et al.: The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987, 106:19-26.
27. 27 Duvic M, Johnson TM, Rapini RP, et al.: Acquired immunodeficiency syndrome associated psoriasis and Reiter's syndrome. Arch Dermatol 1987, 123:1622-1632.
28. 28 Reveille JD, Conant MA, Duvic M: Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? Arthritis Rheum 1990, 33:1574-1578.
29. 29 Leder RO, Farber EM: The variable incidence of psoriasis in sub-Saharan Africa. Int J Dermatol 1997, 36:911-919.
30. 30 Johnson TM, Duvic M, Rapini RP, Rios A: AIDS exacerbates psoriasis [letter]. N Engl J Med 1985, 313:1415.
31. 31 Hill AV: The immunogenetics of human infectious diseases. Annu Rev Immunol 1998, 16:593-617.
32. 32 Ohno S: How cytotoxic T cells manage to discriminate nonself from self at the nonapeptide level. Proc Natl Acad Sci U S A 1992, 89:4643-4647.
33. 33 Gore SM, Hutchinson SJ, Brettle RP: Study requirements for investigating HLA-associated progression of HIV disease, and review. Q J Med 1999, 92:609-617. Provides a sytematic review of the impact on HIV disease progression of HLA antigens B27 and B35 and HLA phenotype A1, B8, DR3, with RR values of 0.33 (95% Cl, 0.16 to 0.70); 2.6 (95% Cl, 1.7 to 4.0); and 2.5 (95% Cl, 1.6 to 3.7), respectively.
34. 34 Kaslow RA, Duquesnoy R, van Raden M, et al.: A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection: a report from the Multicenter AIDS Cohort Study. Lancet 1990, 335:927-930.
35. 35 Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996, 2:405-411.
36. 36 McNeil AJ, Yap PL, Gore SM, et al.: Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. Q J Med 1996, 89:177-185.
37. 37 loannidis JPA, O'Brien TR, Rosenberg PS, et al.: Genetic effects on HIV disease progression. Nat Med 1998, 4:536.
38. 38 Itescu S, Mathur-Wagh U, Skovron ML, et al.: HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr 1991, 5:37-45.
39. 39 Sahmoud T, Laurian Y, Gazengel C, et al.: Progression to AIDS in French haemophiliacs: association with HLA-B35. AIDS 1993, 7:497-500.
40. 40 Multicohort Analysis Project Workshop: Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. AIDS 1994, 8:911-921.
41. 41 Cao Y, Qin L, Zhang L, et al.: Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995, 332:201-208.
42. 42 Pantaleo G, Menzo S, Vaccarezza M, et al.: Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995, 332:209-216.
43. 43 Hill AVS: HIV and HLA: confusion or complexity? Nat Med 1996, 2:395-396.
44. 44 Aubry P, Klotz F, Oddes B, Seurat PL: La rectocolite hémorragique ou colite ulcéreuse chez le Sénéngalais de race noire: a propos de 14 cas. Med Trop 1984, 44:269-278.
45. 45 Wright JP, Froggatt J, O'Keefe EA, et al.: The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J 1986, 70:10-15.
46. 46 Mann DL, Garner RP, Dayhoff DE, et al.: Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans. J Infect Dis 1998, 178:1799-1802.
47. 47 Rowland-Jones S, Sutton J, Ariyoshi K, et al.: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995, 1:59-64.
48. 48 AIDS and Africa [editorial]. Financial Times. January 14, 2000.
49. 49 Wilson D, Cawthome P, Ford N, Aongsonwang S: Global trade and access to medicines: AIDS treatments in Thailand. Lancet 1999, 354:1893-1895. This is a viewpoint expressed by the Medicins Sans Frontières branch in Thailand and discusses the increasing globalization of trade and its negative impact on public health in developing countries. The World Health Organization and nongovernmental organizations should prevent Western trade pressures that make it harder for the developing countries to forego their rights to produce and import the effective drugs at an affordable price.